HLA-F Protein (AA 22-305) (His tag)
-
- Target See all HLA-F (HLAF) Proteins
- HLA-F (HLAF) (HLA Class I alpha F (HLAF))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 22-305
- Origin
- Human
- Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- This HLA-F protein is labelled with His tag.
- Application
- ELISA, Western Blotting (WB)
- Purity
- Greater than 95 % as determined by SDS-PAGE
- Sterility
- 0.2 μm filtered
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex
- Buffer
- Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4
- Storage
- 4 °C,-20 °C
- Storage Comment
- -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution
- Expiry Date
- 12 months
-
- Target
- HLA-F (HLAF) (HLA Class I alpha F (HLAF))
- Alternative Name
- HLA F (HLAF Products)
- Synonyms
- HLAF Protein, CDA12 Protein, HLA-5.4 Protein, HLA-CDA12 Protein, major histocompatibility complex, class I, F Protein, HLA-F Protein
- Background
- CDA12, HLA 5.4, HLA class I histocompatibility antigen, alpha chain F, HLA class I molecule, HLA F antigen, HLA-CDA12, HLA-F, HLAF, HLAF_HUMAN, Leukocyte antigen F, MHC class I antigen F
- Molecular Weight
- 31.1 kDa
- UniProt
- P30511
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-